U.S. Markets closed

NovaBay Pharmaceuticals, Inc. (NBY)


NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
3.900.00 (0.00%)
At close: 3:49PM EDT
People also watch
OPXAIMUCCYCCNAVBLPTN
Full screen
Previous Close3.90
Open3.90
Bid0.00 x
Ask0.00 x
Day's Range3.90 - 4.06
52 Week Range2.12 - 5.29
Volume9,853
Avg. Volume18,639
Market Cap59.71M
Beta-1.29
PE Ratio (TTM)-3.94
EPS (TTM)-0.99
Earnings DateAug 9, 2017 - Aug 14, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.88
Trade prices are not sourced from all markets
  • Accesswire11 days ago

    UPDATE: NovaBay's Avenova Highlighted in National Dry Eye Awareness Month

    The release titled, "NovaBay's Avenova Highlighted in National Dry Eye Awareness Month," issued earlier today by Virgina Eye Consultants, is being re-issued to correct a hyperlink in the first ...

  • Accesswire12 days ago

    NovaBay's Avenova Highlighted in National Dry Eye Awareness Month

    Daily Wipes with a New Eyelid Hygiene Product Can Finally Bring Relief from an Often-Painful Condition, Reports a Top Eye Doctor NORFOLK, VA / ACCESSWIRE / July 10, 2017 / John D. Sheppard, M.D., M.M.Sc ...

  • Business Wire12 days ago

    NovaBay Pharmaceuticals Announces CFO Transition

    NovaBay® Pharmaceuticals, Inc. , a specialty pharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, announces that Jack McGovern will join the company as Chief Financial Officer as of July 17, 2017.